NOVO — Oktober 2025
-
Ikke et nyt fuldt fase 3. Men et bridge studie af meget mindre størrelse og varighed. Præcis hvordan det er designet og hvad man vil måle på ved jeg ikke
-
Men det er lidt lige som de snart starter et fase 3 med ny version af CagriSema. Med en forbedret cagrilintide der betyder den er stabil og kan mixes sammen med semaglutide. Altså at den kan bruge en normal multi dose pen med ét kammer i stedet for den nuværende version hvor pen er med 2 kamre
-
Det fase 3 forsøg bliver heller ikke et stort 72 ugers forsøg. Men meget korter hvor de skal påvise nogle specifikke markøre. At den nye version er som den version de lancere cagrisema med
-
Her artikel fra tradingnews.com: "Novo Nordisk Stock Price Forecast - NVO Shares Rebounds from a 59% Collapse: Deep Value Opportunity or Structural Shift?", der i det store og hele fint oplister casen pt. De har vist liiige fået galt fat på "årets kursstigning" samt "limited U.S. production footprint".. men bortset fra det konkluderer de fornuftigvis, at Novo er et "deep value"-køb.
-
Novo Nordisk Stock Price Forecast - NYSE:NVO Stock Near $59; Deep Value Play as Wegovy Faces Tariff Shock and 2026 Growth Rebound
Trading News Novo Nordisk (NYSE:NVO) trades near $59.63, down 59% from its 2024 peak, yet analysts see up to 30% upside as 2026 catalysts — including oral ...
(www.tradingnews.com)
-
L
ink fundet 06.08 på google-finance site for Novos US notering, https://www.google.com/finance/quote/NVO:NYSE -
Konklusionen: "At $59.63 per share, Novo Nordisk is trading near a valuation floor last seen in early 2022, offering a rare entry point into a blue-chip pharma franchise with global leadership in obesity treatment, industry-leading ROE, and a fortress balance sheet. With a forward P/E of 14 and sector median near 18, the discount alone supports 20–30% potential upside through multiple expansion. The macro setup — falling rates, defensive rotation, and tariff exemptions for U.S. plants — adds to
-
the bullish case.Based on the full data set and technical confirmation of a bottom, the verdict for NYSE:NVO is a decisive Buy. Investors should monitor the $55 support zone as the critical floor and $71 target range for the next 12 months, with a bull-case stretch to $80 if EPS momentum recovers in 2026. This deep-value."
-
indigo: ja. Og ja maks dosis i forsøgene er 14mg
-
For lige at forviere lidt, så er 14mg dosis udgået nu. Den er erstattet af en ny pille med højere bioavailability. Et fancy ord for at novo har lavet en ny forbedret version, hvor mere af selve medicinen kan optages i kroppen. Dermed skal der en mindre dosis til for at opnå samme resultat
-
Så doserne hedder nu 1mg/4mg/9mg. Og så den nye 25mg som novo venter på at få godkendt i US som nye fedme behandling
-
Ja. 14mg skulle sammenlignes med 1mg ozempic. Det er nu 9mg der skal det. Så 61x api. Stadig et meget højt tal, men det øger kapaciteten af deres allerede installerede produktion
-
Novo kan få nyt om de offentlige sygesikringers dækning af vægttabsmidler i USA https://proinvestor.com/investornyt/1368959/novo-kan-fa-nyt-om-de-offentlige-sygesikringers-daekning-af-vaegttabsmidler-i-usa
-
Europæiske sundhedsaktier hævet til "overvægt" af Barclays https://proinvestor.com/investornyt/1369034/europaeiske-sundhedsaktier-haevet-til-overvaegt-af-barclays
-
Investeringspodcasten 292 :AI, kvante, Genmab og optakt til regnskabssæsonen: https://proinvestor.com/boards/128772
-
@ResearchPulse1: $NVO in a few days launch two new brand names for Ozempic and Wegovy in Brazil. With Brazilian Eurofarma.
We now get a glimpse of the prices. About 10% lower than Ozempic/Wegovy.
I don’t think 10% lower prices will move that much. But understandable when semaglutide patent doesn’t expire until marts 26. When that happens I expect the prices to drop minimum 50%.
I also expect to see somewhat similar move from NVO in Canada and China.·
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind